Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage

Pilot trial of a novel two-step therapy protocol using nebulized tranexamic acid and recombinant factor VIIa in children with intractable diffuse alveolar hemorrhage

BACKGROUND AND OBJECTIVES: Diffuse alveolar hemorrhage (DAH) is a life threatening condition with very limited, often unsuccessful, therapeutic options. This study aimed at exploring the feasibility and efficacy of nebulized tranexamic acid TXA (n-TXA) and nebulized recombinant factor VIIa (n-rFVIIa...

Full description

Bibliographic Details
Main Authors: Hind Bafaqih, May Chehab, Suliman Almohaimeed, Farah Thabet, Abdulrahman Alhejaily, Mohammed AlShahrani, Mohammed A. Zolaly, Abeer A. Abdelmoneim, Ehab S. Abd El-Moneim
Format: Article
Language:English
Published: King Faisal Specialist Hospital and Research Centre 2015-05-01
Series:Annals of Saudi Medicine
Online Access:https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2015.231

Internet

https://www.annsaudimed.net/doi/full/10.5144/0256-4947.2015.231

Similar Items